Phakic IOL Surpasses LASIK In Stability And Predictability At 10 Years Postop

Friday, April 15, 2011

Comments

Ocular Surgery News

Despite endothelial cell loss, implantation of an angle-supported phakic IOL for high myopia proved more stable and predictable than LASIK at 10 years, a study found.

Full Story

Refractive Products and Equipment »

Which of the following treatments is FDA approved for the treatment of postoperative pseudophakic cystoid macular edema (Irvine-Gass syndrome)?
1. Topical prednisolone acetate 1% (PredForte) QID
2. Topical ketorolac tromethamine (Acular) QID
3. Topical nepefanac (Nevanac) TID
4. Intravitreal triamcinolone acetonide(Kenalog) in 0.1 cc
5. None of the above
Check The Answer

CareCloud Charts For Ophthalmology
Get all of the tools you need to deliver... view product
SPECTRALIS Diagnostic Imaging Platform
A modular and upgradeable ophthalmic ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

Phakic IOL Surpasses LASIK In Stability And Predictability At 10 Years Postop

Comments

Related Categories

Refractive Products and Equipment »

Quick Quiz

Which of the following treatments is FDA approved for the treatment of postoperative pseudophakic cystoid macular edema (Irvine-Gass syndrome)?

AdGlare RMR Ad

Featured Products

CareCloud Charts For Ophthalmology

SPECTRALIS Diagnostic Imaging Platform

Follow OphthalmologyWeb

AdGlare RMR2

Write for Us